Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.
Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VN, Das P, Berman J, Arana B. Sundar S, et al. Among authors: jha tk. Trop Med Int Health. 2013 Jan;18(1):96-100. doi: 10.1111/tmi.12015. Epub 2012 Nov 8. Trop Med Int Health. 2013. PMID: 23136856 Free article. Clinical Trial.
Oral miltefosine for the treatment of Indian visceral leishmaniasis.
Sundar S, Jha TK, Thakur CP, Bhattacharya SK, Rai M. Sundar S, et al. Among authors: jha tk. Trans R Soc Trop Med Hyg. 2006 Dec;100 Suppl 1:S26-33. doi: 10.1016/j.trstmh.2006.02.011. Epub 2006 May 26. Trans R Soc Trop Med Hyg. 2006. PMID: 16730038 Review.
Amphotericin B in resistant visceral leishmaniasis.
Sahay AS, Jha TK. Sahay AS, et al. Among authors: jha tk. Indian Pediatr. 1996 Jun;33(6):499-501. Indian Pediatr. 1996. PMID: 8979611 Clinical Trial. No abstract available.
Combination therapy in Kala-azar.
Singh NK, Jha TK, Singh IJ, Jha S. Singh NK, et al. Among authors: jha s, jha tk. J Assoc Physicians India. 1995 May;43(5):319-20. J Assoc Physicians India. 1995. PMID: 9081958
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page